Methods and compositions for targeted cleavage and recombination
Disclosed herein are methods and compositions for targeted cleavage of a genomic sequence, targeted alteration of a genomic sequence, and targeted recombination between a genomic region and an exogenous polynucleotide homologous to the genomic region. The compositions include fusion proteins comprising a cleavage domain (or cleavage half-domain) and an engineered zinc finger domain and polynucleotides encoding same. Methods for targeted cleavage include introduction of such fusion proteins, or polynucleotides encoding same, into a cell. Methods for targeted recombination additionally include introduction of an exogenous polynucleotide homologous to a genomic region into cells comprising the disclosed fusion proteins.
1. A method for treating human immunodeficiency virus (HIV) infection in a subject, the method comprising:
(a) inactivating an endogenous gene encoding an HIV viral receptor in an isolated CD4+ cell using first and second fusion proteins, each fusion protein comprising a zinc finger binding domain engineered to bind to a target site in the endogenous gene encoding the HIV viral receptor and a FokI cleavage half-domain, wherein the FokI cleavage half-domain of the first fusion protein includes an amino acid substitution in position 486 and the second fusion protein includes an amino acid substitution in position 490 and further wherein the HIV viral receptor is CCR5 or CXCR4; and
(b) introducing the cell with the inactivated endogenous gene encoding the viral receptor into the subject, thereby treating HIV infection in the subject.
2. The method of claim 1 , wherein the subject is a human.